Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 9/2008

01-09-2008 | Case Report

Acute pseudogout after pamidronate infusion

Authors: Daniel Wendling, Guillaume Tisserand, Vincent Griffond, Clarisse Saccomani, Eric Toussirot

Published in: Clinical Rheumatology | Issue 9/2008

Login to get access

Abstract

A 72-year-old man, treated with a 60-mg intravenous infusion of pamidronate for shoulder hand syndrome, developed after few hours an acute pseudogout arthritis of his right knee. Diagnosis was confirmed by synovial fluid analysis and was associated with hypocalcemia. Only a few cases are reported in the literature. The mechanism of this potential side effect remains speculative.
Literature
1.
Tanvetyanon T, Stiff PJ (2006) Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol 17:897–907PubMedCrossRef
2.
Young-Min SA, Herbert L, Dick M, Fordham J (2005) Weekly alendronate-induced acute pseudogout. Rheumatology 44:131–132PubMedCrossRef
3.
Gallacher SJ, Boyle IT, Capell HA (1991) Pseudogout associated with the use of cyclical etidronate therapy. Scot Med J 36:49PubMed
4.
Malnick SD, Ariel-Ronen S, Evron E, Sthoeger ZM (1997) Acute pseudogout as a complication of pamidronate. Ann Pharmacother 31:499–500PubMed
5.
Diaz-Borjon A, Seyler TM, Chen NL, Lim SS (2006) Bisphosphonate-associated arthritis. J Clin Rheumatol 12:131–133PubMedCrossRef
Metadata
Title
Acute pseudogout after pamidronate infusion
Authors
Daniel Wendling
Guillaume Tisserand
Vincent Griffond
Clarisse Saccomani
Eric Toussirot
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 9/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-0923-z

Other articles of this Issue 9/2008

Clinical Rheumatology 9/2008 Go to the issue

Case Report

A fibromyalgia patient with traumatic cerebrospinal fluid leak: a case report

Original Article

Is there an association between familial Mediterranean fever and celiac disease?

Original Article

Influence of gender and age of onset on the outcome in children with systemic lupus erythematosus

Original Article

Henoch Schonlein purpura in childhood: clinical analysis of 254 cases over a 3-year period

Original Article

Characteristics and medical management of patients with rheumatoid arthritis and ankylosing spondylitis

Original Article

Fast spin echo-T2-weighted sequences with fat saturation in toe dactylitis of spondyloarthritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits